Related Experiment Videos

A mutant (Arg327-->His) GPIIb associated to thrombasthenia exerts a dominant negative effect in stably transfected

M Ferrer1, M Fernández-Pinel, C González-Manchón

  • 1Department of Pathophysiology and Human Molecular Genetics, Centro de Investigaciones Biológicas, (CSIC), Madrid, Spain.

Thrombosis and Haemostasis
|September 1, 1996
PubMed

Insights

A mutation in the GPIIb protein causes Glanzmann thrombasthenia by reducing platelet glycoprotein complex alpha IIb beta 3 expression. This His327GPIIb mutation exhibits a dominant-negative effect, impacting protein maturation and cell surface transport.

Area of Science:

  • Molecular Biology
  • Hematology
  • Biochemistry

Background:

  • Glanzmann thrombasthenia is a bleeding disorder caused by defects in the platelet glycoprotein complex GPIIb-IIIa (integrin alpha IIb beta 3).
  • This complex is crucial for platelet aggregation and hemostasis.

Related Concept Videos